These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23044635)

  • 1. The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review.
    Bellantuono C; Bozzi F; Orsolini L; Catena-Dell'Osso M
    Hum Psychopharmacol; 2012 Nov; 27(6):534-9. PubMed ID: 23044635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The safety profile of escitalopram in pregnancy and breastfeeding].
    Bellantuono C; Orsolini L; Bozzi F
    Riv Psichiatr; 2013; 48(6):407-14. PubMed ID: 24441517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
    Bellantuono C; Vargas M; Mandarelli G; Nardi B; Martini MG
    Hum Psychopharmacol; 2015 May; 30(3):143-51. PubMed ID: 25784291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
    Orsolini L; Bellantuono C
    Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
    Klieger-Grossmann C; Weitzner B; Panchaud A; Pistelli A; Einarson T; Koren G; Einarson A
    J Clin Pharmacol; 2012 May; 52(5):766-70. PubMed ID: 22075232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment of depression during pregnancy and breastfeeding].
    Nielsen RE; Stage KB; Christensen PM; Mortensen S; Andersen LL; Damkier P
    Ugeskr Laeger; 2007 Apr; 169(16):1442-4. PubMed ID: 17484841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors' passage into human milk of lactating women.
    Pogliani L; Baldelli S; Cattaneo D; Pileri P; Clementi E; Cetin I; Zuccotti G
    J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3020-3025. PubMed ID: 29557689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S; Bellantuono C
    J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
    Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C
    Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of fluoxetine during pregnancy and lactation.
    Nulman I; Koren G
    Teratology; 1996 May; 53(5):304-8. PubMed ID: 8879088
    [No Abstract]   [Full Text] [Related]  

  • 12. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
    Malm H
    Ther Drug Monit; 2012 Dec; 34(6):607-14. PubMed ID: 23042258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram.
    Aronson S; Delgado P
    Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram in pregnancy and lactation.
    Heikkinen T; Ekblad U; Kero P; Ekblad S; Laine K
    Clin Pharmacol Ther; 2002 Aug; 72(2):184-91. PubMed ID: 12189365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of first-trimester fluoxetine exposure on the newborn.
    Goldstein DJ; Corbin LA; Sundell KL
    Obstet Gynecol; 1997 May; 89(5 Pt 1):713-8. PubMed ID: 9166307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
    Uguz F
    Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index.
    Gentile S
    Drug Saf; 2007; 30(2):107-21. PubMed ID: 17253877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New antidepressive agents during pregnancy and lactation. Drug concentration should be monitored and the lowest possible dose administered].
    Spigset O; Hägg S
    Lakartidningen; 2004 Mar; 101(13):1176-81. PubMed ID: 15101242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are SSRIs safe for pregnant and breastfeeding women?
    Misri S; Burgmann A; Kostaras D
    Can Fam Physician; 2000 Mar; 46():626-8, 631-3. PubMed ID: 10752001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram-associated serotonin toxicity.
    Vari G; Beckson M
    J Clin Psychopharmacol; 2007 Apr; 27(2):229-30. PubMed ID: 17414259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.